TY  - GEN
AU  - Schmitt,Christina
AU  - Grundt,Alexander
AU  - Buchholtz,Christian
AU  - Scheuer,Lars
AU  - Benner,Axel
AU  - Hensel,Manfred
AU  - Ho,Anthony D
AU  - Leo,Eugen
TI  - One single dose of rituximab added to a standard regimen of CHOP in primary treatment of follicular lymphoma appears to result in a high clearance rate from circulating bcl-2/IgH positive cells: Is the end of molecular monitoring near?
SN  - 0145-2126
PY  - 2007///0928
KW  - Adult
KW  - Aged
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Chromosomes, Human, Pair 14
KW  - genetics
KW  - Chromosomes, Human, Pair 18
KW  - Combined Modality Therapy
KW  - Cyclophosphamide
KW  - Doxorubicin
KW  - Female
KW  - Genes, bcl-2
KW  - Humans
KW  - Immunoglobulin Heavy Chains
KW  - Infusions, Intravenous
KW  - Lymphoma, Follicular
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Prednisone
KW  - Remission Induction
KW  - Reverse Transcriptase Polymerase Chain Reaction
KW  - methods
KW  - Rituximab
KW  - Sensitivity and Specificity
KW  - Treatment Outcome
KW  - Vincristine
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.leukres.2006.01.014
ER  -